SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640455-19-000065
Filing Date
2019-08-07
Accepted
2019-08-07 07:16:40
Documents
3
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnce063020198-k.htm 8-K 27308
2 EXHIBIT 99.1 jnce06302019exhibit991.htm EX-99.1 92654
3 jouncelogosmaller.jpg GRAPHIC 44678
  Complete submission text file 0001640455-19-000065.txt   182509
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37998 | Film No.: 191003817
SIC: 2836 Biological Products, (No Diagnostic Substances)